Table 2 Hospitalizations due to AMI – comparison between 2010, 2019 and 2020
From: Treatment of acute mesenteric ischemia between 2010 and 2020 – a German nation-wide study
Year | 2010 | 2019 | 2020 | Absolute change 2010 - 2019 | Relative change 2010 - 2019 | Absolute change 2019 - 2020 | Relative change 2019 - 2020 |
|---|---|---|---|---|---|---|---|
All hospitalizations, n | 24,172 | 26,684 | 26,124 | +2,512 | +10.4% | -560 | -2.1% |
Age, mean (± sd) | 72.93 (±14.9) | 71.47 (±15.4) | 71.20 (±15.4) | -1 | -2.0% | 0 | -0.4% |
Men, n (%) | 10,053 (41.6) | 12,014 (45.0) | 11,955 (45.8) | +1,961 (+3.4) | +8.3% | -59 (+0.7) | +1.6% |
In-hospital death, n (%) | 8,852 (36.6) | 8,287 (31.1) | 8,050 (30.8) | -565 (-5.6) | -15.2% | -237 (-0.2) | -0.8% |
In-hospital stay, d, median (IQR) | 11 (5-22) | 10 (5-21) | 10 (4-20) | -1 | -9.1% | 0 | 0.0% |
Treatment: | |||||||
endovascular + vascular surgery | 12 (0.0) | 56 (0.2) | 54 (0.2) | +44 (+0.2) | +322.7% | -2 (0.0) | -1.5% |
endovascular + visceral and vascular surgery | 20 (0.1) | 74 (0.3) | 75 (0.3) | +54 (+0.2) | +235.2% | 1 (0.0) | +3.5% |
endovascular + visceral surgery | 56 (0.2) | 203 (0.8) | 260 (1.0) | +147 (+0.5) | +228.4% | 57 (+0.0) | +30.8% |
vascular + visceral surgery | 414 (1.7) | 380 (1.4) | 368 (1.4) | -34 (-0.3) | -16.9% | -12 (0.0) | -1.1% |
conservative treatment | 14,546 (60.2) | 15,320 (57.4) | 14,781 (56.6) | +774 (-2.8) | -4.6% | -539 (-0.8) | -1.5% |
endovascular | 183 (0.8) | 478 (1.8) | 510 (2.0) | +295 (+1.0) | +136.6% | 32 (+0.2) | +9.0% |
vascular surgery | 375 (1.6) | 306 (1.1) | 297 (1.1) | -69 (-0.4) | -26.1% | -9 (0.0) | -0.9% |
visceral surgery | 8,566 (35.4) | 9,867 (37.0) | 9,779 (37.4) | +1,301 (+1.5) | +4.3% | -88 (+0.5) | +1.2% |
Elixhauser domains, n (%): | |||||||
Hypertension (uncomplicated) | 11,188 (46.3) | 13,962 (52.3) | 13,740 (52.6) | +2,774 (+6.0) | +13.0% | -222 (+0.3) | +0.5% |
Hypertension (complicated) | 1,959 (8.1) | 2,047 (7.7) | 1,965 (7.5) | +88 (-0.4) | -5.3% | -82 (-0.1) | -1.9% |
Kidney disease | 5,658 (23.4) | 6,474 (24.3) | 6,290 (24.1) | +816 (+0.9) | +3.7% | -184 (-0.2) | -0.8% |
Cardiac arrhythmias | 7,739 (32.0) | 8,462 (31.7) | 8,409 (32.2) | +723 (-0.3) | -1.0% | -53 (+0.5) | +1.5% |
Diabetes (complicated) | 3,942 (16.3) | 4,468 (16.7) | 4,341 (16.6) | +526 (+0.4) | +2.7% | -127 (-0.1) | -0.8% |
Diabetes (uncomplicated) | 2,052 (8.5) | 1,910 (7.2) | 1,906 (7.3) | -142 (-1.3) | -15.7% | -4 (+0.1) | +1.9% |
Congestive heart failure | 5,675 (23.5) | 6,054 (22.7) | 5,881 (22.5) | +379 (-0.8) | -3.4% | -173 (-0.2) | -0.8% |
Fluid and electrolyte disorders | 11,222 (46.4) | 14,837 (55.6) | 15,207 (58.2) | +3,615 (+9.2) | +19.8% | 370 (+2.6) | +4.7% |
Chronic pulmonary disease | 2,885 (11.9) | 3,400 (12.7) | 3,336 (12.8) | +515 (+0.8) | +6.8% | -64 (0.0) | +0.2% |
Hypothyroidism | 1,916 (7.9) | 3,890 (14.6) | 4,110 (15.7) | +1,974 (+6.7) | +83.9% | 220 (+1.2) | +7.9% |
Obesity | 1,547 (6.4) | 1,837 (6.9) | 1,881 (7.2) | +290 (+0.5) | +7.6% | 44 (+0.3) | +4.6% |
Valvular disease | 1,821 (7.5) | 2,226 (8.3) | 2,351 (9.0) | +405 (+0.8) | +10.7% | 125 (+0.7) | +7.9% |
Depression | 1,297 (5.4) | 1,751 (6.6) | 1,707 (6.5) | +454 (+1.2) | +22.3% | -44 (0.0) | -0.4% |
Coagulopathy | 5,014 (20.7) | 6,290 (23.6) | 6,297 (24.1) | +1,276 (+2.8) | +13.6% | 7 (+0.5) | +2.3% |
Other neurological disorders | 733 (3.0) | 666 (2.5) | 666 (2.5) | -67 (-0.5) | -17.7% | 0 (+0.1) | +2.1% |
Paralysis | 1,237 (5.1) | 1,223 (4.6) | 1,213 (4.6) | -14 (-0.5) | -10.4% | -10 (+0.1) | +1.3% |
Weight loss | 936 (3.9) | 2,940 (11.0) | 2,748 (10.5) | +2,004 (+7.1) | +184.5% | -192 (-0.5) | -4.5% |
Deficiency anemia | 544 (2.3) | 1,048 (3.9) | 1,011 (3.9) | +504 (+1.7) | +74.5% | -37 (-0.1) | -1.5% |
Rheumatoid arthritis/collagen disorders | 424 (1.8) | 585 (2.2) | 563 (2.2) | +161 (+0.4) | +25.0% | -22 (0.0) | -1.7% |
Alcohol abuse | 763 (3.2) | 987 (3.7) | 1,028 (3.9) | +224 (+0.5) | +17.2% | 41 (+0.2) | +6.4% |
Pulmonary circulation disorders | 819 (3.4) | 1,169 (4.4) | 1,199 (4.6) | +350 (+1.0) | +29.3% | 30 (+0.2) | +4.8% |
Liver disease | 1,964 (8.1) | 3,622 (13.6) | 3,549 (13.6) | +1,658 (+5.4) | +67.1% | -73 (0.0) | +0.1% |
Solid tumor without metastasis | 2,362 (9.8) | 3,176 (11.9) | 2,988 (11.4) | +814 (+2.1) | +21.8% | -188 (-0.5) | -3.9% |
Blood loss anemia | 770 (3.2) | 1,145 (4.3) | 1,082 (4.1) | +375 (+1.1) | +34.7% | -63 (-0.1) | -3.5% |
Metastatic cancer | 853 (3.5) | 1,438 (5.4) | 1,415 (5.4) | +585 (+1.9) | +52.7% | -23 (0.0) | +0.5% |
Psychoses | 179 (0.7) | 207 (0.8) | 181 (0.7) | +28 (0.0) | +4.8% | -26 (-0.1) | -10.7% |
Drug abuse | 377 (1.6) | 144 (0.5) | 183 (0.7) | -233 (-1.0) | -65.4% | 39 (+0.2) | +29.8% |
Lymphoma | 140 (0.6) | 169 (0.6) | 164 (0.6) | +29 (+0.1) | +9.4% | -5 (0.0) | -0.9% |
Peptic ulcer disease, excluding bleeding | 197 (0.8) | 161 (0.6) | 155 (0.6) | -36 (-0.2) | -26.0% | -6 (0.0) | -1.7% |
AIDS / HIV | 6 (0.0) | 10 (0.0) | 14 (0.1) | +4 (0.0) | +51.0% | 4 (0.0) | +43.0% |
Elixhauser score, median (IQR) | 3 (2-5) | 4 (2-5) | 4 (2-5) | +1 | +33.3% | 0 | 0.0% |
Elixhauser score, mean (±sd) | 3.3 ± 2.2 | 3.8 ± 2.4 | 3.9 ± 2.4 | +0.5 | +14.3% | 0.0 | +1.3% |
vWS, median (IQR) | 9 (4-16) | 10 (5-18) | 10 (5-18) | +1 | +11.1% | 0 | 0.0% |
vWS, mean (±sd) | 10.1 ± 8.6 | 11.9 ± 9.9 | 12.0 ± 9.8 | +1.8 | +18.4% | +0.1 | +0.8% |